1. Shikonin regulates C-MYC and GLUT1 expression through the MST1-YAP1-TEAD1 axis
   Karel Vališ et al, 2016, Experimental Cell Research CrossRef
2. Metabolic profiling study of shikonin's cytotoxic activity in the Huh7 human hepatoma cell line
   E. D. Spyrelli et al, 2017, Molecular BioSystems CrossRef
3. Cytotoxicity and antigenotoxicity evaluation of acetylshikonin and shikonin
   Ramona Figat et al, 2021, Drug and Chemical Toxicology CrossRef
4. Synthesis, biological function and evaluation of Shikonin in cancer therapy
   Fangfang Wang et al, 2019, Fitoterapia CrossRef
5. Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells
   Christin Durchschein et al, 2018, Molecules CrossRef
6. In Vitro Anti-Photoaging and Skin Protective Effects of Licania macrocarpa Cuatrec Methanol Extract
   Kon Kuk Shin et al, 2022, Plants CrossRef
7. SIRT2 mediated antitumor effects of shikonin on metastatic colorectal cancer
   Li-Li Zhang et al, 2017, European Journal of Pharmacology CrossRef
8. Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway
   Shu Li et al, 2023, Skin Research and Technology CrossRef
9. Shikonin suppresses trophoblast cell growth via regulation of GLI1, and p62 mediated caspase 8 activation
   Yanxi Wang et al, 2020, Reproductive Toxicology CrossRef
10. Shikonin induces mitochondria-mediated apoptosis and attenuates epithelial-mesenchymal transition in cisplatin-resistant human ovarian cancer cells
    Kristina Shilnikova et al, 2018, Oncology Letters CrossRef
11. Yes-associated protein promotes the abnormal proliferation of psoriatic keratinocytes via an amphiregulin dependent pathway
    Jinjing Jia et al, 2018, Scientific Reports CrossRef
12. Therapeutic Effects of Shikonin on Skin Diseases: A Review
    Zhenzhen Mu et al, 2021, The American Journal of Chinese Medicine CrossRef